Cellular Biomedicine Group, Inc. (20) | Business Finance (11)

Browse by Subcategory

Recent Contracts

BRIDGE LOAN AGREEMENT (Filed With SEC on October 26, 2020)
Nanjing Bank approval of a credit line of up to RMB 30 million to CBMG Wuxi (Filed With SEC on August 12, 2020)
Facility Improvement and Process Validation Agreement (Filed With SEC on August 29, 2019)
Underwriting Agreement, dated March 21, 2019, by and among Cellular Biomedicine Group, Inc., Cantor Fitzgerald& Co. and Robert W. Baird & Co. Incorporated, as representatives of... (Filed With SEC on March 22, 2019)
Pledge Agreement, dated as of January 9, 2019, by and between Cellular Biomedicine Group Ltd. (HK) and China Merchants Bank Co., Ltd., Shanghai Branch (Filed With SEC on January 25, 2019)
China Merchants Bank approval of a credit line of up to RMB 30 million to SBM Shanghai (Filed With SEC on August 12, 2020)
Bridge Loan Agreement, dated as of August 11, 2020, by and between Cellular Biomedicine Group, Inc. and Yunfeng Capital Limited (Filed With SEC on August 12, 2020)
Amendment Letter, dated as of August 11, 2020, by and between Cellular Biomedicine Group, Inc. and Winsor Capital Limited in relation to the Bridge Loan Agreement, dated as of... (Filed With SEC on August 12, 2020)
Nanjing Bank approval of a credit line of up to RMB 30 million to CBMG Wuxi (Filed With SEC on May 6, 2020)
BRIDGE LOAN AGREEMENT (Filed With SEC on January 29, 2020)
Credit Agreement, dated as of January 19, 2019, by and between Shanghai Cellular Biopharmaceutical Group Ltd. and China Merchants Bank Co., Ltd., Shanghai Branch (Filed With SEC on January 25, 2019)